- Home
- MNOV vs DMA Comparison
MNOV vs DMA Comparison
Compare MNOV & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNOV
- DMA
- Stock Information
- Founded
- MNOV 2000
- DMA 2011
- Country
- MNOV United States
- DMA United States
- Employees
- MNOV N/A
- DMA N/A
- Industry
- MNOV Biotechnology: Pharmaceutical Preparations
- DMA Trusts Except Educational Religious and Charitable
- Sector
- MNOV Health Care
- DMA Finance
- Exchange
- MNOV Nasdaq
- DMA Nasdaq
- Market Cap
- MNOV 65.7M
- DMA 78.8M
- IPO Year
- MNOV 2005
- DMA N/A
- Fundamental
- Price
- MNOV $1.22
- DMA $8.67
- Analyst Decision
- MNOV Strong Buy
- DMA
- Analyst Count
- MNOV 2
- DMA 0
- Target Price
- MNOV $7.00
- DMA N/A
- AVG Volume (30 Days)
- MNOV 24.9K
- DMA 34.6K
- Earning Date
- MNOV 11-12-2025
- DMA 01-01-0001
- Dividend Yield
- MNOV N/A
- DMA 2.04%
- EPS Growth
- MNOV N/A
- DMA N/A
- EPS
- MNOV N/A
- DMA N/A
- Revenue
- MNOV $134,599.00
- DMA N/A
- Revenue This Year
- MNOV N/A
- DMA N/A
- Revenue Next Year
- MNOV N/A
- DMA N/A
- P/E Ratio
- MNOV N/A
- DMA N/A
- Revenue Growth
- MNOV N/A
- DMA N/A
- 52 Week Low
- MNOV $1.13
- DMA $4.78
- 52 Week High
- MNOV $2.55
- DMA $8.00
- Technical
- Relative Strength Index (RSI)
- MNOV 41.14
- DMA 47.04
- Support Level
- MNOV $1.23
- DMA $8.68
- Resistance Level
- MNOV $1.26
- DMA $8.85
- Average True Range (ATR)
- MNOV 0.03
- DMA 0.11
- MACD
- MNOV -0.00
- DMA 0.01
- Stochastic Oscillator
- MNOV 16.67
- DMA 45.45
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.